News

February 27, 2019

Cellphire Awarded Subaward for DARPA Biostasis Program

Cellphire, Inc., the global leader in long-term stabilization and storage of platelets, announced today that the Defense Advanced Research and Development Authority (DARPA) has awarded the company a seven-figure contract in conjunction with the University of North Carolina at Chapel Hill for Research Aimed to Extend the Golden Hour for Life Saving Post Traumatic Treatment under the DARPA Biostasis Program.

May 1, 2018

Keith A. Moskowitz joins Cellphire as Vice President for Discovery

Cellphire, Inc., the global leader in long-term stabilization and storage of platelets, announced today that Keith A. Moskowitz, Ph.D. MPM, has joined the company as Vice President of Discovery.

March 1, 2018

Dr. Heather F. Pidcoke joins Cellphire, Inc. as Chief Medical Officer

Cellphire, Inc., the global leader in long-term stabilization and storage of platelets, announced today that Heather Pidcoke, MD, MSCI, Ph.D., has joined the company as Chief Medical Officer.

November 6, 2017

Cellphire Investors Receive Maryland Biotechnology Investment Incentive Tax Credit

Cellphire, Inc., the global leader in long-term stabilization and storage of platelets, announced today that investors who participated in the $3,000,000 Cellphire funding round that closed in June have received their Final Tax Credit Certificates from the Maryland Department of Commerce awarding them a 50 percent refundable tax credit for their investments in Cellphire.

September 4, 2017

BodeVet Chief Technical Officer to Present at IVECCS 2017

BodeVet Chief Technical Officer, Anne Hale, CVM, will advise on controversies in blood banking at the International Veterinary Emergency and Critical Care Symposium, (IVECCS) 2017 in Nashville, Tennessee.

July 10, 2017

Cellphire Awarded Grant to Develop Elephant Endotheliotropic Herpesvirus (EEHV) Freeze Platelet Treatment

Thanks to a grant from the International Elephant Foundation, Cellphire, Smithsonian Global Health Program, Ringling Bros. Center for Elephant Conservation, Fort Worth Zoo and Houston Zoo have made great strides in developing a novel treatment for a lethal virus afflicting baby Asian elephants around the globe. Elephant Endotheliotropic Herpesvirus (EEHV) is the leading cause of death among captive Asian elephants under 12 years of age. EEHV attacks blood vessels and frequently causes uncontrolled hemorrhage, causing the victim to die of blood loss.

June 5, 2017

Cellphire Closes $3,000,000 Funding Round

Cellphire, Inc. announced today that it had closed a $3,000,000.00 funding round, with investments from both new investors and exisiting investors, management, and the board of directors.

April 3, 2017

Dr. David Hirsh Joins Cellphire, Inc. Board of Directors

Cellphire, Inc. announced today that David I. Hirsh, Ph.D. has joined the Company’s Board of Directors. Dr. Hirsh is a Professor in the Department of Biochemistry and Molecular Biophysics at the College of Physicians and Surgeons of Columbia University.